These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 27641667)
21. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939 [TBL] [Abstract][Full Text] [Related]
22. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells]. Qin AD; Liu XX; Li J; Liu J; Li YS Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764 [No Abstract] [Full Text] [Related]
23. MiR-369-5p inhibits the proliferation and migration of hepatocellular carcinoma cells by down-regulating HOXA13 expression. Qian X; Wang Y; Hu W; Xu X; Gao L; Meng Y; Yan J Tissue Cell; 2022 Feb; 74():101721. PubMed ID: 34979376 [TBL] [Abstract][Full Text] [Related]
24. miR-34a-5p plays an inhibitory role in hepatocellular carcinoma by regulating target gene VEGFA. Niu X; Wei N; Peng L; Li X; Zhang X; Wang C Malays J Pathol; 2022 Apr; 44(1):39-52. PubMed ID: 35484885 [TBL] [Abstract][Full Text] [Related]
25. MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma. Yan TH; Qiu C; Sun J; Li WH Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3038-3046. PubMed ID: 29863248 [TBL] [Abstract][Full Text] [Related]
26. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma. Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866 [TBL] [Abstract][Full Text] [Related]
28. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1. Du X; Fan W; Chen Y Gene; 2018 May; 657():30-38. PubMed ID: 29505836 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-126-5p suppresses cell proliferation, invasion and migration by targeting EGFR in liver cancer. Zhao Y; Ye L; Yu Y Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):865-873. PubMed ID: 32409283 [TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression. Hu B; Cai H; Zheng R; Yang S; Zhou Z; Tu J Int J Biochem Cell Biol; 2017 Nov; 92():34-42. PubMed ID: 28919047 [TBL] [Abstract][Full Text] [Related]
31. MiR-139-5p, miR-940 and miR-193a-5p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1. Li P; Xiao Z; Luo J; Zhang Y; Lin L J Cell Mol Med; 2019 Apr; 23(4):2475-2488. PubMed ID: 30710422 [TBL] [Abstract][Full Text] [Related]
32. LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR-10a-5p/NCOR2 axis in hepatocellular carcinoma cells. Wu Y; Zhou Y; Huan L; Xu L; Shen M; Huang S; Liang L Cancer Sci; 2019 Mar; 110(3):973-984. PubMed ID: 30680848 [TBL] [Abstract][Full Text] [Related]
33. MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2. Li H; Sun Q; Han B; Yu X; Hu B; Hu S Int J Clin Exp Pathol; 2015; 8(5):4782-90. PubMed ID: 26191168 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP. Xian Y; Wang L; Yao B; Yang W; Mo H; Zhang L; Tu K Biomed Pharmacother; 2019 Oct; 118():109343. PubMed ID: 31545279 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA‑302a inhibits cell proliferation and invasion, and induces cell apoptosis in hepatocellular carcinoma by directly targeting VEGFA. Qin C; Zha W; Fan R; Ding H; Xu Y; Wang C Mol Med Rep; 2017 Nov; 16(5):6360-6367. PubMed ID: 28849033 [TBL] [Abstract][Full Text] [Related]
36. MiR-486-5p Suppresses Proliferation and Migration of Hepatocellular Carcinoma Cells through Downregulation of the E3 Ubiquitin Ligase CBL. He J; Xiao B; Li X; He Y; Li L; Sun Z Biomed Res Int; 2019; 2019():2732057. PubMed ID: 31976317 [TBL] [Abstract][Full Text] [Related]
37. Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC. Xu J; Wang Y; Zhang Y; Dang S; He S Biomed Pharmacother; 2018 Nov; 107():1682-1691. PubMed ID: 30257386 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163 [TBL] [Abstract][Full Text] [Related]
39. Downregulation of miR-1225-5p is pivotal for proliferation, invasion, and migration of HCC cells through NFκB regulation. Liu L; Zhang W; Hu Y; Ma L; Xu X J Clin Lab Anal; 2020 Nov; 34(11):e23474. PubMed ID: 32720731 [TBL] [Abstract][Full Text] [Related]
40. CircSNX6 promotes proliferation, metastasis, and angiogenesis in hepatocellular carcinoma via miR-383-5p/VEGFA signaling pathway. Tian Y; Han W; Lv K; Fu L; Zhou X Sci Rep; 2024 Apr; 14(1):8243. PubMed ID: 38589413 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]